The chemical class known as NKG2-A Activators comprises compounds that target and enhance the expression or functional activity of the NKG2-A receptor on natural killer (NK) cells, a vital part of the innate immune system. These activators function by upregulating NKG2-A expression or modulating the associated signaling pathways. NKG2-A, an inhibitory receptor, plays a crucial role in immune regulation by transmitting inhibitory signals to NK cells, thus preventing the destruction of healthy cells and maintaining immune homeostasis. The action of NKG2-A Activators in modulating this critical checkpoint is central to the balance of NK cell activity.
These activators exhibit specificity in interacting with molecular components that regulate NKG2-A expression or function. This interaction can be direct, like binding to the NKG2-A receptor, or indirect, through the modulation of cellular pathways and transcription factors governing the receptor's expression. The chemical structures of NKG2-A Activators are diverse, reflecting the variety of mechanisms they employ. Some may influence epigenetic modifications, altering NK cell gene expression to favor NKG2-A expression. Others interact with intracellular signaling molecules and pathways, enhancing NKG2-A receptor expression or its inhibitory signaling. This diversity underscores their complex role in the immune system's intricate network. By modulating NKG2-A activity, these activators contribute to the fine-tuning of immune responses, ensuring effective NK cell functioning within the broader context of immune surveillance and homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, might promote NKG2-A expression by altering gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that could upregulate NKG2-A expression via epigenetic modifications. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor, might promote NKG2-A gene expression by altering chromatin structure. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor that could enhance NKG2-A expression by modifying epigenetic markers. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
As an HDAC inhibitor, could potentially upregulate NKG2-A expression by altering gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
An HDAC inhibitor that might increase NKG2-A expression by affecting gene expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Could potentially induce NKG2-A expression by influencing proteasomal degradation pathways. | ||||||